Jedd Levine, Chief Medical Officer, Revere Pharmaceuticals, USA
Revere has had a first-rate and productive partnership with Eurofins Advinus, Bangalore, India for over 2 years. During this time, we have performed ADME/DMPK and IND safety assessment studies at Eurofins Advinus. The team was highly experienced, professional, and enthusiastic, providing scientific insights and communicating effectively, while addressing any technical challenges during the engagement period. Amid the COVID pandemic, all our timelines were met, and the quality of the data and reports were excellent. We are extremely pleased with the services provided by Eurofins Advinus for our preclinical drug development program and IND-enabling studies and would enthusiastically recommend their high-quality services to others.